Business
Multiply Labs Announces New Collaboration to Automate Cell Therapy Manufacturing with Robotics
SAN FRANCISCO, January 27, 2026--AstraZeneca collaborates with Multiply Labs to scale cell therapy manufacturing using end-to-end GMP-ready robotic technology.
About this update from Astrazeneca Plc
[{"type":"image","alt":"Cell therapies are among the most promising, yet complex medicines being developed today. Multiply Labs' mission is to make these therapies more widely available by increasing manufacturing efficiency and scale through robotic automation.","displaySize":"","headline":null,"caption":"Cell therapies are among the most promising, yet complex medicines being developed today. Multiply Labs' mission is to make these therapies more widely available by increasing manufacturing efficiency and scale through robotic automation.","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":320,"url":"https://media.zenfs.com/en/business-wire.com/f835305dff339cac8c7e226b0c29ff60"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/f9qkTaRULMKdeC2poHQGSw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/f835305dff339cac8c7e226b0c29ff60","width":480,"height":320}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":270,"url":"https://media.zenfs.com/en/business-wire.com/e9c955a8fbffbffdb1e38df32e55010d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/XcBGkAr9EcqymKhY4nJLDQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU0MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/e9c955a8fbffbffdb1e38df32e55010d","width":480,"height":270}}},{"type":"text","content":"Collaboration with AstraZeneca will focus on scaling cell therapy manufacturing using GMP-ready end-to-end robotic biomanufacturing technology","length":142,"tagName":"p","attribs":{}},{"type":"text","content":"SAN FRANCISCO, January 27, 2026--(BUSINESS WIRE)--Multiply Labs today announced an agreement with AstraZeneca to evaluate the potential for applying GMP-ready robotic systems to commercial-scale cell therapy manufacturing. Multiply Labs is a current leader in autonomous manufacturing technology for advanced therapies.","length":319,"tagName":"p"},{"type":"text","content":"The collaboration will focus on end-to-end robotic automation of industry-standard instruments used in cell therapy production using Multiply Labs’ robotic biomanufacturing system. The goal is to enable scalable, high-throughput manufacturing while maintaining the rigorous quality and regulatory standard...